Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesCarbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysisStrategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of ChinaClinical management of infections caused by multidrug-resistant EnterobacteriaceaeGenomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.Designer aminoglycosides prevent cochlear hair cell loss and hearing lossEnterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidencePredictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-TanzaniaTranscriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective AntibioticsPredictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.Polyclonal spread and outbreaks with ESBL positive gentamicin resistant Klebsiella spp. in the region Kennemerland, The Netherlands.Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010.Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinicaCharacterization of TEM-1 β-Lactamase-Producing Kingella kingae Clinical Isolates.Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011Plasmid-mediated AmpC: prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriageDirect RNA-based detection and differentiation of CTX-M-type extended-spectrum β-lactamases (ESBL).Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemESBLs: A Clear and Present Danger?Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp.Antibiotic consumption and its influence on the resistance in EnterobacteriaceaeNon-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.How to treat severe infections in critically ill neutropenic patients?Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceMolecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionUrinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular EpidemiologyPrevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda.Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.Frequency, Antimicrobial Resistance and Genetic Diversity of Klebsiella pneumoniae in Food Samples.Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceDecreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada
P2860
Q26799580-58F6D324-EF99-42A1-85E1-431C1E3A49B8Q27002495-2DE7799B-AB9E-4BB4-B12C-69717E755C55Q28082780-2D9D0B08-FFC8-41C5-9DEB-FB8E9895597FQ28246841-15CACB10-436A-4E6B-B976-48154D6B8708Q30376979-6C6C6A6C-4069-4A2A-AC9F-A4D992FA8012Q30619790-234B5EB8-A628-4987-8AB3-E46361697926Q33410364-FE125DE9-AA7C-4336-AC37-624A6C88B00FQ33564316-F6BEA8AF-E95B-4C5B-BBC5-49D9712AB89CQ33595291-868AA6F0-0552-4D3C-A4A0-68775BFD9DB5Q33790123-D2DC4A07-7AFD-4DF3-8BF3-10618AA50DE3Q33798081-242B1510-AFAA-4765-88E4-F63A5F77475DQ33817429-8BEEAB84-DE5F-491E-9190-061215EEFA50Q33826293-723A31AF-AA9B-4E9C-8447-02571B4674F6Q34133346-B6412B4C-430D-4704-9BCA-7C99213378F3Q34140513-6EA99008-8C12-49C0-A27D-D3D0C76C2E10Q34150900-F245909F-3249-48D8-B1E8-6A360DADA8E3Q34296375-14BB643E-9B6D-4BE0-AE62-8009643B656CQ34298258-0471FAAB-79F8-481F-AB88-D691700B2895Q34353194-9E74D2E3-D50D-426F-84A3-4B6D1001C5A3Q34525373-FBF616EA-7E70-49E4-B1CC-4E9FB5148EA4Q34960683-4F980327-F457-461D-86A9-98B83F22BE25Q34960838-159B2877-5480-4569-8A46-B11983449C48Q35041607-D388DCFD-5395-4F21-93AA-E5D084AEE40FQ35065875-ADA49FEE-CBA6-428A-8387-B687A06B167AQ35101453-DA01AFBA-E284-4A78-9498-534CB7616380Q35156063-F5659617-FDD9-4703-ACA3-AA5AD3AE26C4Q35207302-EC10FD6D-FAB9-4CDE-A52F-0CE925EC4354Q35297743-D93E7108-4443-4969-BBF4-F95CFF6F3EF0Q35457899-C42EF93A-C275-444A-8EAB-51C264922421Q35656192-C14D3DE2-CBB0-4506-A0EF-819B9E40F6E8Q35681590-2E17365C-E250-4AB3-9311-9E4C59FCD94BQ35689028-00122922-B0EB-4A63-92C7-C6BB219A5C8EQ35735182-7B74B259-3383-448C-A2BA-6D530E56376EQ35776482-43484801-CB7F-42A0-A3BD-6938F7E2B991Q35921039-7D555EBB-CF22-4581-B92F-FF5D24388040Q35979859-BBCEECD3-941D-4F4F-A883-F03AA4730F29Q35989920-E2DD7BFB-B8B6-44D0-8BFF-10C91AD3EDFFQ36018566-6F56579E-CC1A-44D7-87BA-074440E8C226Q36076066-B54413BC-5438-4021-BCD4-32A2C5A2BC0FQ36086414-4EF70B98-B684-437E-B81A-B15AE32670B1
P2860
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Predictors of mortality in pat ...... itial antimicrobial treatment.
@ast
Predictors of mortality in pat ...... itial antimicrobial treatment.
@en
type
label
Predictors of mortality in pat ...... itial antimicrobial treatment.
@ast
Predictors of mortality in pat ...... itial antimicrobial treatment.
@en
prefLabel
Predictors of mortality in pat ...... itial antimicrobial treatment.
@ast
Predictors of mortality in pat ...... itial antimicrobial treatment.
@en
P2093
P2860
P50
P356
P1476
Predictors of mortality in pat ...... itial antimicrobial treatment.
@en
P2093
Barbara Fiori
Eva Montuori
Giovanni Fadda
Mario Tumbarello
Rita Citton
Teresa Spanu
Tiziana D'Inzeo
P2860
P304
P356
10.1128/AAC.01509-06
P407
P577
2007-03-26T00:00:00Z